124 related articles for article (PubMed ID: 9886608)
1. Incidental non-Hodgkin's lymphoma in patients with localized prostate cancer.
Eisenberger CF; Walsh PC; Eisenberger MA; Chow NH; Partin AW; Mostwin JL; Marshall FF; Epstein JI; Schoenberg M
Urology; 1999 Jan; 53(1):175-9. PubMed ID: 9886608
[TBL] [Abstract][Full Text] [Related]
2. Five-year prognosis after radical prostatectomy in a patient with localized prostate cancer and incidental non-Hodgkin's lymphoma.
Drinis S; Finkelstein MP; Tortorelis DG; Konno S; Choudhury MS
Urol Int; 2001; 66(2):105-7. PubMed ID: 11223753
[TBL] [Abstract][Full Text] [Related]
3. Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer.
Han M; Partin AW; Zahurak M; Piantadosi S; Epstein JI; Walsh PC
J Urol; 2003 Feb; 169(2):517-23. PubMed ID: 12544300
[TBL] [Abstract][Full Text] [Related]
4. Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: continued risk of biochemical failure after 5 years.
Amling CL; Blute ML; Bergstralh EJ; Seay TM; Slezak J; Zincke H
J Urol; 2000 Jul; 164(1):101-5. PubMed ID: 10840432
[TBL] [Abstract][Full Text] [Related]
5. Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence.
Capitanio U; Scattoni V; Freschi M; Briganti A; Salonia A; Gallina A; Colombo R; Karakiewicz PI; Rigatti P; Montorsi F
Eur Urol; 2008 Jul; 54(1):118-25. PubMed ID: 18314255
[TBL] [Abstract][Full Text] [Related]
6. Hematolymphoid malignancies diagnosed at the time of radical prostatectomy.
Terris MK; Hausdorff J; Freiha FS
J Urol; 1997 Oct; 158(4):1457-9. PubMed ID: 9302142
[TBL] [Abstract][Full Text] [Related]
7. Era specific biochemical recurrence-free survival following radical prostatectomy for clinically localized prostate cancer.
Han M; Partin AW; Piantadosi S; Epstein JI; Walsh PC
J Urol; 2001 Aug; 166(2):416-9. PubMed ID: 11458039
[TBL] [Abstract][Full Text] [Related]
8. Metachronous non-Hodgkin's lymphoma in a patient with localized prostate cancer.
Kalender ME; Sevinc A; Tutar E; Buyukberber S; Camci C
Med Oncol; 2007; 24(4):466-8. PubMed ID: 17972182
[TBL] [Abstract][Full Text] [Related]
9. Does capsular incision at radical retropubic prostatectomy affect disease-free survival in otherwise organ-confined prostate cancer?
Barocas DA; Han M; Epstein JI; Chan DY; Trock BJ; Walsh PC; Partin AW
Urology; 2001 Nov; 58(5):746-51. PubMed ID: 11711353
[TBL] [Abstract][Full Text] [Related]
10. Effect of perioperative blood transfusion on prostate cancer recurrence.
Ford BS; Sharma S; Rezaishiraz H; Huben RS; Mohler JL
Urol Oncol; 2008; 26(4):364-7. PubMed ID: 18367097
[TBL] [Abstract][Full Text] [Related]
11. Robotic assisted laparoscopic prostatectomy versus radical retropubic prostatectomy for clinically localized prostate cancer: comparison of short-term biochemical recurrence-free survival.
Barocas DA; Salem S; Kordan Y; Herrell SD; Chang SS; Clark PE; Davis R; Baumgartner R; Phillips S; Cookson MS; Smith JA
J Urol; 2010 Mar; 183(3):990-6. PubMed ID: 20083261
[TBL] [Abstract][Full Text] [Related]
12. [Perioperative parameters and prognosis analysis of patients aged 80 years or older treated with radical prostatectomy for prostate cancer].
Zhang F; Zhang SD; Xiao CL; Huang Y; Ma LL
Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Oct; 50(5):822-827. PubMed ID: 30337742
[TBL] [Abstract][Full Text] [Related]
13. Radical retropubic prostatectomy in immunosuppressed transplant recipients.
Thompson RH; Leibovich BC; Karnes RJ; Bergstralh EJ; Blute ML
J Urol; 2008 Apr; 179(4):1349-52; discussion 1352-3. PubMed ID: 18289598
[TBL] [Abstract][Full Text] [Related]
14. Long-term outcome following radical prostatectomy in men with clinical stage T3 prostate cancer.
Carver BS; Bianco FJ; Scardino PT; Eastham JA
J Urol; 2006 Aug; 176(2):564-8. PubMed ID: 16813890
[TBL] [Abstract][Full Text] [Related]
15. Radical retropubic prostatectomy in men younger than 45 years diagnosed during early prostate cancer detection program.
Varkarakis J; Pinggera GM; Sebe P; Berger A; Bartsch G; Horninger W
Urology; 2004 Feb; 63(2):337-41. PubMed ID: 14972485
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Biochemical Recurrence-Free Survival after Radical Prostatectomy Triggered by Grade Reclassification during Active Surveillance and in Men Newly Diagnosed with Similar Grade Disease.
Diniz CP; Landis P; Carter HB; Epstein JI; Mamawala M
J Urol; 2017 Sep; 198(3):608-613. PubMed ID: 28347771
[TBL] [Abstract][Full Text] [Related]
17. Impact of Radical Prostatectomy on Long-Term Oncologic Outcomes in a Matched Cohort of Men with Pathological Node Positive Prostate Cancer Managed by Castration.
Bhindi B; Rangel LJ; Mason RJ; Gettman MT; Frank I; Kwon ED; Tollefson MK; Thompson RH; Boorjian SA; Karnes RJ
J Urol; 2017 Jul; 198(1):86-91. PubMed ID: 28130104
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcome of incidental pelvic node malignant B-cell lymphomas discovered at the time of radical prostatectomy.
He H; Cheng L; Weiss LM; Chu PG
Leuk Lymphoma; 2007 Oct; 48(10):1976-80. PubMed ID: 17917966
[TBL] [Abstract][Full Text] [Related]
19. PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer.
Roberts SG; Blute ML; Bergstralh EJ; Slezak JM; Zincke H
Mayo Clin Proc; 2001 Jun; 76(6):576-81. PubMed ID: 11393495
[TBL] [Abstract][Full Text] [Related]
20. Anatomic radical retropubic prostatectomy-long-term recurrence-free survival rates for localized prostate cancer.
Chun FK; Graefen M; Zacharias M; Haese A; Steuber T; Schlomm T; Walz J; Karakiewicz PI; Huland H
World J Urol; 2006 Aug; 24(3):273-80. PubMed ID: 16506049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
